Liliorchids

VRNA- After Success, What's Next

NASDAQ:VRNA   Verona Pharma plc
VRNA reached the trend resistance line and has acted tough in the past. Such volatility on stock chart is gaining market attention. The company presently has an “outperform” rating on the stock. I can feel this stock has a potential upside of 101.1% from its current price of $5.36.
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.